Publications Office of the EU
Open House Original discount agreements 2025-32 - Doravirin/Lamivudine/Tenofovir (combination of active ingredients) - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

Open House Original discount agreements 2025-32 - Doravirin/Lamivudine/Tenofovir (combination of active ingredients)

Overview
  • Published
    13/10/2025
  • Today
    20/05/2026
  • Deadline
    30/11/2027
  • Opening of tenders
    30/11/2027
Status
Published
Type of contract
Supplies
Subject for Renewal
No
Buyer
Techniker Krankenkasse
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: DE600 Hamburg
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
Not available
Procedure details
Tender reference number
OH-Originale-2025-32
Description

The aim of the TK is to conclude discount agreements with all suitable pharmaceutical entrepreneurs pursuant to § 130c(1) SGB V for the active substance combination doravir/lamivudine/tenofovir. The contract is concluded within the framework of the TK's open-house original procedure: Individual negotiations on contract contents are not conducted, uniform conditions apply. TK does not guarantee any exclusivity to individual contractual partners. The duration of the contract is a maximum of 24 months starting on 01.12.2025. The contract ends no later than 30.11.2027, regardless of the date of conclusion of the contract. If the patent expires/market exclusivity expires before the above-mentioned end date, the contract ends automatically at the end of the month of the patent expiry/market exclusivity. Joining this open-house original procedure is possible at any time within the contract period. Due to the existence of industrial property rights with regard to the active substance or the combination of active substances at issue in the proceedings, the participation and contractual documents are only made available to pharmaceutical entrepreneurs who offer/place on the market medicinal products for the active substance or combination of active substances at issue in the proceedings or who make it credible to TK that they intend to offer/place such medicinal products on the market within the term of the contract. The information provided on the binding period is not relevant in this case and is solely due to the mandatory requirements of the form. All further information can be found in the participation and contract documents.

Submission Method
Not available
Tenders may be submitted
Electronic submission: eu.europa.publications.PublicProcurement.electronic.submission.not-allowed
tdf-non-av
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
30/11/2027 23:59
Buyers
Handelskrankenkasse (hkk)
HEK - Hanseatische Krankenkasse
Place of performance
DE Deutschland
DE600 Hamburg
CPV code

33600000 - Pharmaceutical products

Award method
Not available
Estimated value
Not available
Final contracted value
Not available
Award of contract
Not available
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.